Fresh off a major marketing campaign which saw their branding projected into millions of Aussie households as broadcast partners of the Tokyo 2020 Olympic Games, neo-lender Wisr (ASX: WZR) have reported 280% revenue growth to be eyeing profitability for the first time in their short history. Emerging as the non-bank lender of choice amongst the
Read More
With well over a year of working from home under our belts it’s safe to say that hybrid and remote work is no longer a temporary solution. Our new way of working has spurred the growth of some organisations providing solutions to enhance the digital working experience. LiveTiles (ASX: LVT) is one such company, creating
Read More
In what may be the first of two pitch invasions this week, Sydney-siders have celebrated the rare achievement of reaching 1,000 daily COVID cases by storming Gladys Berejiklian’s office to give her a pat on the back. The office invasion, a first in Australian history for the feat achieved, comes with the Premier today confirming
Read More
Following the $39 billion takeover from global payments company Square, early stage investors of Afterpay (ASX: APT) will be pleased the deal was done prior to the release of their FY21 results which show the handbrake has been pulled on growth in the BNPL market. While the percentage figures at the top of their results
Read More
Further consolidating their position as the largest operator of regional veterinary clinics, Apiam Animal Health (ASX: AHX) is continuing its acquisition spree with Harbour City Veterinary Surgery the latest to join their network at a time when pet ownership has soared. The clinic is located in Gladstone, Queensland, which is a rapidly growing town south-east
Read More
The complex nature of cancer means that scientists are having to get creative to improve diagnosis and treatment. Experts in the field of oncology ‘theranostics’ (combined therapeutic and diagnostic solutions), Clarity Pharmaceuticals (ASX: CU6) is due to make it’s ASX debut today. Clarity has raised $92 million at $1.40 per share. Upon listing their indicative
Read More